Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	553.68	649.27	6.37	10.72	29.47	19.38
Short-Term Investments	-	-	45.36	2.41	1.51	1.08
Trading Asset Securities	-	-	-	8.08	3.08	0.58
Cash & Short-Term Investments	553.68	649.27	51.73	21.21	34.05	21.04
Cash Growth	534.29%	1155.15%	143.94%	-37.73%	61.84%	81.16%
Accounts Receivable	970.33	926.85	1,771	648.49	345.6	902.73
Other Receivables	-	-	-	-	-	0.16
Receivables	982.61	935.56	1,776	650.95	347.11	903.79
Inventory	3,725	2,698	2,399	1,750	1,501	464.6
Restricted Cash	-	0.54	0.5	0.38	3.38	0.26
Other Current Assets	364.1	698.31	45.02	149.49	276.34	136.81
Total Current Assets	5,626	4,982	4,272	2,572	2,162	1,526
Property, Plant & Equipment	1,518	1,176	524.89	461.53	386.26	322.82
Long-Term Investments	319.88	132.18	19.93	4.66	0.03	0.03
Other Intangible Assets	6.96	6.32	4.27	4.2	3.08	0.56
Other Long-Term Assets	264.91	124.32	52.98	33.61	21.32	19.98
Total Assets	7,736	6,421	4,874	3,076	2,573	1,870

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,226	875.83	1,448	629.47	593.43	486.17
Accrued Expenses	-	61.01	60.62	27.98	27.47	24.45
Short-Term Debt	-	-	1,506	867.6	677.09	186.19
Current Portion of Long-Term Debt	1,658	1,661	69.21	59.52	33.98	-
Current Portion of Leases	-	197.51	12.37	-	-	-
Current Income Taxes Payable	132.28	95.41	71.16	55.35	42.9	27.91
Other Current Liabilities	390.95	77.95	113.92	28.36	21.7	12.79
Total Current Liabilities	3,408	2,969	3,281	1,668	1,397	737.5
Long-Term Debt	869.34	563.1	96.13	127.98	154.4	420.39
Pension & Post-Retirement Benefits	-	19.43	18.56	11.62	9.97	10.03
Long-Term Deferred Tax Liabilities	112.75	65.48	44.84	41.37	38.43	14.31
Other Long-Term Liabilities	41.85	23.13	19.77	12.04	9.67	7.05
Total Liabilities	4,431	3,640	3,460	1,861	1,609	1,189

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	169	54.73	47.22	46.99	45.32	44.33
Additional Paid-In Capital	-	1,624	727.73	714.27	549.69	454.12
Retained Earnings	-	952.95	628.39	437.73	285.48	180.04
Comprehensive Income & Other	3,135	149.54	10.5	15.72	83.27	2.13
Total Common Equity	3,304	2,781	1,414	1,215	963.76	680.61
Minority Interest	-0	-0	-	-	-	-
Shareholders' Equity	3,304	2,781	1,414	1,215	963.76	680.61
Total Liabilities & Equity	7,736	6,421	4,874	3,076	2,573	1,870

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	2,527	2,422	1,684	1,055	865.47	606.59
Net Cash (Debt)	-1,974	-1,772	-1,632	-1,034	-831.41	-585.54
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-113.41	-110.88	-117.20	-74.24	-61.89	-47.01
Filing Date Shares Outstanding	16.9	16.42	14.16	14.1	13.6	13.3
Total Common Shares Outstanding	16.9	16.42	14.16	14.1	13.6	13.3
Working Capital	2,218	2,013	991.06	903.72	765.54	788.99
Book Value Per Share	195.51	169.39	99.81	86.17	70.88	51.18
Tangible Book Value	3,297	2,775	1,410	1,211	960.68	680.05
Tangible Book Value Per Share	195.10	169.01	99.51	85.87	70.65	51.14
Land	-	90.63	5.24	5.24	5.24	5.24
Buildings	-	341.56	220.93	220.93	210.02	210.02
Machinery	-	1,029	501.84	391.07	289.59	198.63

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error